参考文献/References:
[1] Abajobir AA,Abate KH,Abbafati C,et al.Global,regional,and national disability-adjusted life-years(DALYs)for 333 diseases and injuries and healthy life expectancy(HALE)for 195 countries and territories,1990~2016:a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet,2017,390(10100):1260-1344.
[2] Storhaug HM,Norvik JV,Toft I,et al.Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from the Tromso Study[J].BMC Cardiovasc Disord,2013,13(1):115.
[3] 国钰梅,马 龙,包成月,等.急性缺血性脑卒中患者尿酸水平与出院结局的关联研究[J].现代检验医学杂志,2015,30(3):17-20.
Guo YM,Ma L,Bao CY,et al.Relationship between uric acid levels in patients with acute ischemic stroke and discharged outcome[J].Journal of Modern Laboratory Medicine,2015,30(3):17-20.
[4] Hayden D,McCarthy C,Akijian L,et al.Renal dysfunction and chronic kidney disease in ischemic stroke and transient ischemic attack: A population-based study[J].Int J Stroke,2017,12(7):761-769.
[5] Carr SJ,Wang X,Olavarria VV,et al.Influence of renal impairment on outcome for thrombolysis-treated acute ischemic stroke: ENCHANTED(enhanced control of hypertension and thrombolysis stroke study)post hoc analysis[J].Stroke,2017,48(9):2605-2609.
[6] Makin SD,Cook FA,Dennis MS,et al.Cerebral small vessel disease and renal function:systematic review and meta-analysis[J].Cerebrovasc Dis,2015,39(1):39-52.
[7] Jauch EC,Saver JL,Adams HP J,et al.Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2013,44(3):870-947.
[8] Hemphill JC,Greenberg SM,Anderson CS,et al.Guidelines for the management of spontaneous intracerebral hemorrhage:A guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2015,46(7):2032-2060.
[9] Kellum JA,Lameire N,KDIGO AKI guideline work group.Diagnosis,evaluation,and management of acute kidney injury:a KDIGO summary(Part 1)[J].CritCare,2013,17(1):204.
[10] Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members.Evaluation and management of chronic kidney disease:synopsis of the kidney disease:improving global outcomes 2012 clinical practice guideline[J].Ann Intern Med,2013,158(11):825-830.
[11] Feng JF,Qiu L,Zhang L,et al.Multicenter study of creatinine-and/orcystatin C-based equations for estimation of glomerular filtration rates in Chinese patients with chronic kidney disease[J]. PLoS One,2013,8(3):e57240.
[12] Fabbian F,Gallerani M, Pala M,et al.Association between in hospitalmortality and renal dysfunction in 186 219 patients hospitalized for acute stroke in the Emilia-romagna region of Italy[J].Angiology,2014,65(10):906-910.
[13] Banerjee A,Fauchier L,Vourc HP,et al.Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation:the Loire Valley Atrial Fibrillation Project[J].J Am Coll Cardiol,2013,61(20):2079-2087.
[14] Sandsmark DK,Messé SR,Zhang XM,et al.Proteinuria,but not eGFR,predicts stroke risk in chronic kidney disease:chronic renal insufficiency cohort study[J].Stroke,2015,46(8):2075-2080.
[15] Martinez Ana-Isabel C,Weinh(¨overa)upl K,Lee Wing-Kee,et al.Biochemical and structural characterization of the interaction between the siderocalin NGAL/LCN2(Neutrophil Gelatinase-associated Lipocalin/Lipocalin 2)and theN-terminal domain of its endocytic receptor SLC22A17[J].J Biol Chem,2016,291(6):2917-2930.
[16] Segal HC,Burgess AI,Poole DL,et al.Population-based study of bloodbiomarkers in prediction of subacute recurrent stroke[J].Stroke,2014,45(10):2912-2917.
[17] Greisenegger S, Segal HC, Burgess AI,et al.Bio-markers and mortality after TIA and minor ischemic stroke: population-based study[J].Stroke,2015,46(3):659-666.
[18] Ronco C,Legrand M,Goldstein SL,et al.Neutro-phil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective[J].Blood Purif,2014,37(4):271-285.
相似文献/References:
[1]张 华,詹 颉,苏宝凤,等.血清NGAL与肾功其它指标联合检测在原发性高血压肾病早期诊断中的应用[J].现代检验医学杂志,2016,31(04):54.[doi:10.3969/j.issn.16717-414.2016.04.014]
ZHANG Hua,ZHAN Jie,SU Bao-feng,et al.Application of Detecting Serum NGAL Combined with Other Renal
Function Index in Early Diagnosis of Essential Hypertension Nephropathy[J].Journal of Modern Laboratory Medicine,2016,31(02):54.[doi:10.3969/j.issn.16717-414.2016.04.014]
[2]詹 颉,张 华,闫福堂,等.血清NGAL与Cr,BUN,RBP,Cys-C联合检测在糖尿病肾病早期诊断中的应用[J].现代检验医学杂志,2016,31(04):100.[doi:10.3969/j.issn.16717-414.2016.04.028]
ZHAN Jie,ZHANG Hua,YAN Fu-tang,et al.Application of Combined Detection of Serum NGAL and Cr,BUN,RBP
and Cys C in Early Diagnosis of Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2016,31(02):100.[doi:10.3969/j.issn.16717-414.2016.04.028]
[3]白香妮,张 英.血清Cys C,NGAL及尿IL-18对ICU儿童急性肾损伤的早期诊断价值[J].现代检验医学杂志,2017,32(05):104.[doi:10.3969/j.issn.1671-7414.2017.05.017]
BAI Xiang-ni,ZHANG Ying.Early Diagnostic Value of the Detection of Serum Cys C,NGAL
and Urinary IL-18 for Acute Kidney Injury in Pediatric Intensive Care Units[J].Journal of Modern Laboratory Medicine,2017,32(02):104.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[4]白雪梅,李月玲,于培红,等.中国长寿地区中老年人群脑卒中发生率调查及其与高血压、糖尿病、心脏病的相关性分析[J].现代检验医学杂志,2018,33(01):5.[doi:10.3969/j.issn.1671-7414.2018.01.001]
BAI Xue-mei,LI Yue-Ling,YU Pei-hong,et al.Incidence of Cerebral Apoplexy in the Elderly Population
in Longevity Areas in China and Its Correlation
with Hypertension,Diabetes and Heart Disease[J].Journal of Modern Laboratory Medicine,2018,33(02):5.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[5]杨宏秀,刘 丽,张会芬,等.血清抗中性粒细胞胞浆抗体及相关炎性因子检测对糖尿病肾病的诊断价值[J].现代检验医学杂志,2018,33(05):95.[doi:10.3969/j.issn.1671-7414.2018.05.025]
YANG Hong-xiu,LIU Li,ZHANG Hui-fen,et al.Diagnostic Value of Detection Anti-Cardiolipin Antibodies and Related Inflammatory Factors in Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2018,33(02):95.[doi:10.3969/j.issn.1671-7414.2018.05.025]
[6]邢延芳,张 艳,艾江波,等.延安市宝塔区40岁以上常住人口随机抽样筛查脑卒中高危人群血清Hcy水平与性别及年龄差异[J].现代检验医学杂志,2018,33(05):111.[doi:10.3969/j.issn.1671-7414.2018.05.030]
XING Yan-fang,ZHANG Yan,AI Jiang-bo,et al.Homocysteine Comparison in Different Gender and Age Groups with High Risk of Stroke of Permanent Residents over Forty Years Old in Baota District of Yan'an[J].Journal of Modern Laboratory Medicine,2018,33(02):111.[doi:10.3969/j.issn.1671-7414.2018.05.030]
[7]赵 雅a,陈会生b,郑 伟a.缺血性脑卒中患者外周血D-二聚体、hs-CRP及血小板参数在不同TOAST分型中的差异研究[J].现代检验医学杂志,2019,34(02):60.[doi:10.3969/j.issn.1671-7414.2019.02.016]
ZHAO Yaa,CHEN Hui-shengb,ZHENG Weia.Study on the Differences of D-dimer,hs-CRPand Platelet Parameters in Peripheral Blood of Patientswith Ischemic Stroke in Different TOAST Classifications[J].Journal of Modern Laboratory Medicine,2019,34(02):60.[doi:10.3969/j.issn.1671-7414.2019.02.016]
[8]郭 娜a,马 英a,王琳莹a,等.脑卒中患者血清 Hcy及 NSE水平与癫痫发作的相关性研究[J].现代检验医学杂志,2022,37(01):177.[doi:10.3969/j.issn.1671-7414.2022.01.036]
GUO Naa,MA Yinga,WANG Lin-yinga,et al.Correlation between Serum Hcy, NSE Levels and Epileptic Seizures in Patients with Stroke[J].Journal of Modern Laboratory Medicine,2022,37(02):177.[doi:10.3969/j.issn.1671-7414.2022.01.036]